ondansetron for reducing Ketamine related vomiting in childre
Phase 3
- Conditions
- nasea and vomitting.???? ? ???????
- Registration Number
- IRCT201301189162N7
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Exclusion criteria are: allergy to ketamine or ondansetron, seizure, air way disease, head trauma, uncontrolled high blood pressure and vomiting associated with other diseases.children (6 months to 10 years) who will referre to emergency department of Imam or Shariati hospitals will be included.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vomitting. Timepoint: before procedure/during procedure/after discharge. Method of measurement: with quastion form.
- Secondary Outcome Measures
Name Time Method Pulse Rate. Timepoint: Continuously during procedure time. Method of measurement: Pulse Oximetry.;Saturation of peripheral O2 (SpO2). Timepoint: Continuously during procedure time. Method of measurement: Pulse Oximetry.;Other Side effects like: Seizure, Shivering,. Timepoint: In Recovery Period. Method of measurement: Observation.